MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-02-2026
AngioDynamics Total Liabilities 2011-2026 | ANGO
Annual Total Liabilities AngioDynamics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97.2 M | 112 M | 154 M | 128 M | 122 M | 139 M | 222 M | 163 M | 193 M | 220 M | 229 M | 262 M | 265 M | 198 M | 31.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 265 M | 31.8 M | 169 M |
Quarterly Total Liabilities AngioDynamics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.3 M | 86.8 M | 97.2 M | 99.5 M | 105 M | 97 M | 112 M | 106 M | 98.4 M | 66.1 M | 154 M | 145 M | 150 M | 144 M | 128 M | 113 M | 122 M | 120 M | 122 M | 122 M | 134 M | 129 M | 139 M | 139 M | 111 M | 76.3 M | 222 M | 222 M | 234 M | 149 M | 163 M | 163 M | 177 M | 182 M | 193 M | 193 M | 189 M | 214 M | 219 M | 219 M | 213 M | 225 M | 213 M | 225 M | 255 M | 257 M | 256 M | 256 M | 266 M | 273 M | 264 M | 265 M | 252 M | 194 M | 197 M | 198 M | 32.7 M | 30.3 M | 31.7 M | 31.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 273 M | 30.3 M | 161 M |
Total Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
17.9 K | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
308 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
iRhythm Technologies
IRTC
|
867 M | $ 122.35 | 0.73 % | $ 3.92 B | USA |
 |
Alcon
ALC
|
9.52 B | $ 75.8 | -0.08 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
11.2 M | $ 3.96 | -0.75 % | $ 183 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.1 M | $ 10.99 | 1.48 % | $ 26.7 M | USA |
 |
The Cooper Companies
COO
|
4.16 B | $ 64.42 | -0.82 % | $ 12.8 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.4 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.34 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
85.8 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.94 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
2.38 B | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
680 M | $ 59.93 | 0.52 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
20.4 M | $ 6.18 | -0.08 % | $ 52.4 K | USA |
 |
ICU Medical
ICUI
|
315 M | $ 124.82 | 0.22 % | $ 3.08 B | USA |
 |
Envista Holdings Corporation
NVST
|
2.62 B | $ 26.8 | -0.89 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
59.9 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
2.52 B | $ 482.22 | 0.71 % | $ 172 B | USA |
 |
Pulse Biosciences
PLSE
|
13.9 M | $ 23.02 | -5.07 % | $ 1.55 B | USA |
 |
Glaukos Corporation
GKOS
|
479 M | $ 121.48 | 0.5 % | $ 5.88 B | USA |
 |
Microbot Medical
MBOT
|
3.99 M | $ 2.2 | 0.92 % | $ 101 M |  Israel |
 |
STAAR Surgical Company
STAA
|
107 M | $ 25.67 | 3.34 % | $ 1.27 B | USA |
 |
STERIS plc
STE
|
3.53 B | $ 221.8 | -0.77 % | $ 21.9 B | USA |
 |
Masimo Corporation
MASI
|
1.57 B | $ 178.63 | -0.04 % | $ 9.52 B | USA |
 |
Milestone Scientific
MLSS
|
4.99 M | $ 0.32 | -1.27 % | $ 26.3 M | USA |
 |
InfuSystem Holdings
INFU
|
51.4 M | $ 10.34 | 0.68 % | $ 214 M | USA |
 |
Stereotaxis
STXS
|
33.5 M | $ 1.93 | -1.53 % | $ 176 M | USA |
 |
Merit Medical Systems
MMSI
|
1.1 B | $ 68.58 | -0.04 % | $ 4.06 B | USA |
 |
Teleflex Incorporated
TFX
|
3.82 B | $ 136.56 | -0.07 % | $ 6.09 B | USA |
 |
Utah Medical Products
UTMD
|
3.27 M | $ 67.17 | -1.03 % | $ 218 M | USA |
 |
West Pharmaceutical Services
WST
|
1.09 B | $ 306.16 | -1.14 % | $ 22.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
4.09 B | $ 11.91 | 0.08 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
68.3 M | $ 0.65 | 0.2 % | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
24.6 M | $ 52.1 | 2.24 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
222 M | $ 113.45 | 0.49 % | $ 2.57 B | USA |
 |
Predictive Oncology
POAI
|
5.17 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
50.6 M | $ 21.38 | -1.57 % | $ 985 M | USA |
 |
Baxter International
BAX
|
14 B | $ 18.16 | -1.39 % | $ 9.32 B | USA |
 |
ResMed
RMD
|
1.74 B | $ 219.85 | 0.15 % | $ 32.1 B | USA |
 |
AtriCure
ATRC
|
162 M | $ 29.28 | 3.79 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
66.3 M | $ 6.86 | 1.18 % | $ 305 M | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
Becton, Dickinson and Company
BDX
|
30.7 B | $ 152.14 | -1.74 % | $ 43.8 B | USA |
 |
Nephros
NEPH
|
3.5 M | $ 2.87 | 1.06 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
62.3 M | $ 3.0 | -1.64 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
866 M | $ 117.6 | 3.1 % | $ 6.55 M | USA |